Oxalatoplatinum en es it fr

Oxalatoplatinum Brand names, Oxalatoplatinum Analogs

Oxalatoplatinum Brand Names Mixture

  • No information avaliable

Oxalatoplatinum Chemical_Formula


Oxalatoplatinum RX_link


Oxalatoplatinum fda sheet

Oxalatoplatinum FDA

Oxalatoplatinum msds (material safety sheet)

Oxalatoplatinum MSDS

Oxalatoplatinum Synthesis Reference

No information avaliable

Oxalatoplatinum Molecular Weight

395.27 g/mol

Oxalatoplatinum Melting Point

No information avaliable

Oxalatoplatinum H2O Solubility

No information avaliable

Oxalatoplatinum State


Oxalatoplatinum LogP

No information avaliable

Oxalatoplatinum Dosage Forms

No information avaliable

Oxalatoplatinum Indication

For the treatment of malignant neoplasm of colon, rectum, and ovary

Oxalatoplatinum Pharmacology

Oxaliplatin selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Oxaliplatin-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.

Oxalatoplatinum Absorption

No information avaliable

Oxalatoplatinum side effects and Toxicity

No information avaliable

Oxalatoplatinum Patient Information

Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.

Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.

Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.

Oxalatoplatinum Organisms Affected

Humans and other mammals